Ultimovacs’ Announces Review Article Highlighting Telomerase-based Therapeutic Cancer Vaccines

NEXT STORY
Ultimovacs Announces Review Article Highlighting Telomerase-based Therapeutic Cancer Vaccines
PREV STORY
Valneva to Host Symposium on COVID-19 and Chikungunya Vaccine Candidates at 31st European Congress of Clinical Microbiology & Infectious Diseases
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AzurRx Announces Appointment of Dr. James Pennington as Chief Medical Officer

NEW YORK, May 30, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or ...

author_avatar
NASDAQ Market News

Horizon Pharma plc Announces Pricing of Private Offering of Senior Notes

DUBLIN, Ireland, Oct. 20, 2016 (GLOBE NEWSWIRE) -- Horizon Pharma plc (Nasdaq:HZNP) (“Horizon”), a ...

author_avatar
NASDAQ Market News

La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2018 and Recent Corporate Progress

SAN DIEGO, May 10, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq:LJPC), a ...

author_avatar
NASDAQ Market News